HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells-Reference-Cited by-同舟云学术

HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells

Published:2002-10 Issue:10 Volume:22 Page:1560-1566
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Zhong Dian-sheng¹,Lu Xiang-huai¹,Conklin Brian S.¹,Lin Peter H.¹,Lumsden Alan B.¹,Yao Qizhi¹,Chen Changyi¹

Affiliation:

1. From the Winship Cancer Institute (D.Z.) and Department of Medicine (X.L.), Emory University, Atlanta, Ga, and the Michael E. DeBakey Department of Surgery (B.S.C., P.H.L., A.B.L., Q.Y., C.C.), Baylor College of Medicine, Houston, Tex.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Viral dynamics in human immunodeficiency virus type 1 infection

2. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

3. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

4. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

5. Vascular complications associated with use of HIV protease inhibitors

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms;Acta Pharmacologica Sinica;2024-09-09

2. Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments;Circulation Research;2024-05-24

3. Advanced 3D Electrospinning “Xspin” System: Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery;Molecular Pharmaceutics;2024-01-18

4. Ritonavir Has Reproductive Toxicity Depending on Disrupting PI3K/PDK1/AKT Signaling Pathway;Toxics;2024-01-15

5. Toxic Medications in Mitochondrial Optic Neuropathies;Advances in Ophthalmology and Optometry;2023-08